Guidance
Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers.
Is this guidance up to date?
Next review: 2025
Guidance development process
How we develop NICE diagnostics guidance
NICE medical technologies guidance addresses specific technologies notified to NICE by companies. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice.
This guidance replaces NICE's medtech innovation briefing on 3C Patch System for treating diabetic foot ulcers (MIB230).